genomics funding
49 open opportunities tagged genomics, across federal agencies and private foundations. Sorted by deadline.
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
S. technology development and commercialization.
7 review criteria on fileNCI Community Oncology Research Program (NCORP) Academic Community Sites (UG1 Clinical Trials Not Allowed)
Purpose This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human research study results through accrual in a variety of community settings.
7 review criteria on fileNCI Community Oncology Research Program (NCORP) Community Sites (UG1 Clinical Trial Not Allowed)
Purpose This Notice of Funding Opportunity (NOFO) is one of three NOFOs for the National Cancer Institute (NCI) Community Oncology Research Program (NCORP). NCORP is designed to enhance generalizability and dissemination of clinical trial and other human research study results through accrual in a variety of community settings.
7 review criteria on fileAnimal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Objective ORIP uses the P40 mechanism to support Animal and Biological Material Resource Centers in a variety of areas of biomedical science.
9 review criteria on fileDARPA DPA26BZ05-DV020 — Universal Cell Culture Platform for Rapid Establishment of Species-Agnostic Cell Lines and Autonomous Culture Operations
Develop and demonstrate a universal, species-agnostic cell culture platform that (1) enables rapid establishment of viable, reproducible cell lines - including induced pluripotent stem cells (iPSCs) where feasible - from diverse non-model species (vertebrate and invertebrate); (2) leverages autonomous, closed-loop culture automation to…
3 review criteria on fileAtopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional)
Research Objectives Atopic Dermatitis (AD) is a chronic inflammatory pruritic skin disease that affects approximately 11% of children and up to 9% of adults in the United States.
13 review criteria on fileLimited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Research Objectives The NIEHS invites qualified investigators from domestic institutions of higher education to submit an application for an SRP Center grant.
22 review criteria on fileResource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Experimental research models are indispensable for studying the genetic basis and pathobiological mechanisms underlying human diseases, identifying drug targets, and developing effective preventive and therapeutic approaches.
7 review criteria on fileSingle Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
This is a Notice of Funding Opportunity (NOFO) for a Single Source that will invite application(s) from eligible organization(s) to apply. Please see Section III.
7 review criteria on fileHEAL INITIATIVE: INTERACT Data Coordination and Integration Center (U24 Clinical Trial Not Allowed)
The goal of this announcement is to support a Data Coordination and Integration Center (DCIC) as part of the NIH HEAL Initiative’s INTERACT program. The DCIC will curate, harmonize, and integrate comprehensive clinical, -omics, and other complex datasets generated by INTERACT as well as from the larger HEAL Initiative related datasets.
7 review criteria on fileNovel Experiential Technologies Assisting Individual Learning (NExT AI) Hubs (P20 Clinical Trial Optional)
Background Children and adolescents (defined here as birth through age 18) are increasingly exposed to and engaged with artificial intelligence (AI) technologies across both formal and informal learning environments.
12 review criteria on fileLimited Competition: Intellectual and Developmental Disabilities Research Centers 2027 (P50 Clinical Trial Optional)
Purpose This is a Notice of Funding Opportunity (NOFO) for a Limited Competition that will invite application(s) from eligible organization(s) to apply. Please see Section III.
17 review criteria on fileNew Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
The purpose of this funding opportunity is to encourage multidisciplinary investigators to develop new approaches or apply existing approaches in novel ways to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment.
3 review criteria on fileNIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
Purpose This Notice of Funding Opportunity (NOFO) will support, through the cooperative agreement mechanism, investigator-initiated observational studies or biomarker validation studies that require prospective collection of data/biospecimens or continued analysis of data/biospecimens collected previously.
4 review criteria on fileScreening and Functional Validation of Genomic Variants Associated with Human Congenital Anomalies (R01 Clinical Trial Not Allowed)
Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including structural congenital anomalies (SCAs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs).
3 review criteria on fileAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
The National Library of Medicine (NLM) wishes to advance groundbreaking and innovative research in bioinformatics, translational bioinformatics and computational biology, which are related areas of biomedical informatics that aim to understand biological data using storage, analytic and interpretive methods.
3 review criteria on fileResearch Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
Purpose Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort studies that address specific knowledge gaps in cancer etiology and survivorship.
3 review criteria on fileNHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
This Notice of Funding Opportunity (NOFO) invites applications to use NHLBI-funded TransOmics for Precision Medicine (TOPMed) program to access TOPMed capacity to generate a large volume of integrated genetic and multi-omics data to facilitate discovery of the molecular mechanisms of Heart, Lung, Blood, and Sleep (HLBS) disorders.
6 review criteria on fileTranslational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
The Ultra-Rare Gene-Based Therapy (URGenT) network supports Investigational New Drug (IND)-enabling studies and planning activities for First-in-Human (FIH) clinical testing of gene-based or transcript-directed therapeutics, such as oligonucleotides and viral-based gene therapies, for ultra-rare neurological or neuromuscular disorders.
3 review criteria on fileINCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
The INCLUDE Transformative Research Award Program supports collaborative investigative teams or individual scientists who propose unusually innovative research projects, which, if successful, would have a major impact in understanding the biology of Down syndrome or related co-occurring conditions, or development of new treatments for…
3 review criteria on fileAdvancing Research on Empirically-Supported Interventions for Older Adults Living with Serious Mental Illness (SMI) (R01 Clinical Trial Optional)
Key Definitions for this NOFO: Older adult: For the purposes of this announcement, "older adult" is defined as individuals with SMI who are 50 years of age and older.
3 review criteria on fileNew Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
The purpose of this funding opportunity is to encourage multidisciplinary investigators to submit applications developing exploratory, highly novel new approaches, or innovative applications of existing approaches to measure brain activity, connectivity, genomics, or other aspects across the age spectrum of neurodevelopment.
3 review criteria on fileEthical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Small Research Grant (R03) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research. These applications should be for small, self-contained research projects, such as those that involve single investigators.
3 review criteria on filePRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (UG3/UH3 Clinical Trial Optional)
Purpose Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) NOFOs seek to spur on the development of innovative, reliable, cost-effective, and sustainable multimodal AI-based clinical decision support (CDS) tools with the potential for transformational impact.
3 review criteria on fileEthical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
This Notice of Funding Opportunity (NOFO) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genetic or genomic research.
3 review criteria on fileEthical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
The purpose of this NOFO is to invite Research Project (R01) applications that propose to study the ethical, legal, and social implications (ELSI) of human genetics and genomics. Applications may propose studies using either single or mixed methods.
3 review criteria on fileUsing Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 CT Not Allowed)
The secondary use of archived data and/or biospecimen collections represents a critical opportunity to advance research in maternal, pediatric, and adolescent HIV. These resources enable investigators to validate prior findings, address novel hypotheses, and generate insights that extend beyond the scope of the original studies.
3 review criteria on fileGREGoRi Technology Integration Center (U01, Clinical Trials Optional)
Background and Program Overview Over the last decade, rapid advancements in the development of high throughput and cost-effective genome sequencing technologies have made it possible to obtain a precise molecular diagnosis for many individuals with an undiagnosed but likely genetic disease.
3 review criteria on filePopulation Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
S.gov/research/nida-research-programs-activities/population-assessment-tobacco-health-path-study/data-access ).
Review criteria on fileGREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
Background and Program Overview Over the last decade, rapid advancements in the development of high throughput and cost-effective genome sequencing technologies have made it possible to obtain a precise molecular diagnosis for many individuals with an undiagnosed but likely genetic disease.
3 review criteria on fileGREGoRi Innovation Projects (U01 Clinical Trial Optional)
Background and Program Overview Over the last decade, rapid advancements in the development of high throughput and cost-effective genome sequencing technologies have made it possible to obtain a precise molecular diagnosis for many individuals with an undiagnosed but likely genetic disease.
3 review criteria on fileSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data.
3 review criteria on fileEarly-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
Purpose Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on the inception and early-stage development of highly innovative technologies with new or improved capabilities for targeting, probing, or assessing molecular and…
4 review criteria on fileAdvanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
Purpose Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on further development and validation of emerging technologies with new or improved capabilities for targeting, probing, or assessing molecular and cellular features of…
4 review criteria on fileSecondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
). The goal of this initiative is to address key scientific questions relevant to cancer by supporting the analysis of existing clinical, environmental, surveillance, health services, vital statistics, behavioral, lifestyle, genomic, and molecular profiles data.
3 review criteria on fileDiscovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
gov/bill/113th-congress/house-bill/2019/text ), for an initial 10 years, 2015-2024.0 by the 118th Congress for an additional five years, and the program was transferred from The Common Fund to the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI).
7 review criteria on fileBlueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
The purpose of this Notice of Funding Opportunity (NOFO) is to provide funding, resources, and expertise to accelerate the development of diverse biotherapeutic modalities — including but not limited to antibodies, peptides, proteins, oligonucleotides, gene therapies, cell therapies, and other emerging therapeutic modalities — for the…
3 review criteria on fileInvestigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease.
3 review criteria on fileNIDA Animal Genomics Program (U01 Clinical Trial Not Allowed)
The purpose of the NIDA Animal Genetics Program is to identify genetic, genomic, and molecular (epi)genetic variants that underlie: 1.g.
3 review criteria on fileInvestigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics relevant to one or both of basic or clinical genomic science, and broadly applicable to human health and disease.
3 review criteria on fileSupporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
This Notice of Funding Opportunity is intended to identify and support research projects by exceptionally promising Early Stage Investigators with a long-term career interest in pursuing innovative research in genomics.
3 review criteria on fileAccelerating Discovery through Partnered Research with All of Us to Analyze Participant Biospecimens (X01 Clinical Trial Not Allowed)
Purpose The purpose of this Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR) is to solicit applications to access the processed and stored biospecimens from the All of Us Research Program supported Biobank to advance the program's mission of accelerating health research and medical breakthroughs,…
6 review criteria on fileLaboratory Flexible Funding Model (LFFM)
This cooperative agreement is intended to enhance the capacity and capabilities of state human and animal food testing laboratories in support of an integrated food safety system (IFSS).
10 review criteria on fileAnimal and Veterinary Innovation Centers (U18)
The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for inclusion as Animal and Veterinary Innovation Centers, which are intended to form long-term partnerships to address priority areas for FDA's Center for Veterinary Medicine (CVM).
Review criteria on fileVet-LIRN Capacity-Building Project and Equipment Grants (U18)
The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include: 1.
Alex's Lemonade Stand Foundation — Featured Researcher
Heinrich Kovar, PhD | Alex's Lemonade Stand Foundation for Childhood Cancer Skip to main content Search form Search Search Donate Alex's Lemonade Stand Foundation for Childhood Cancer Fighting childhood cancer, one cup at a time.
Division of Integrative Organismal Systems Core Programs
The Division of Integrative Organismal Systems (IOS) Core Programs Track supports research to understand why organisms are structured the way they are and function as they do. Proposals are welcomed in all of the core scientific program areas supported by the Division of Integrative Organismal Systems (IOS).
2 review criteria on file · agency frameworkPlant Genome Research Program
The Plant Genome Research Program (PGRP) supports genome-scale research that addresses challenging questions of biological, societal and economic importance. PGRP encourages the development of innovative tools, technologies, and resources that empower a broad plant research community to answer scientific questions on a genome-wide scale.
2 review criteria on file · agency frameworkPlant Biotic Interactions
The Plant Biotic Interactions (PBI) program supports research on the processes that mediate beneficial and antagonistic interactions between plants and their viral, bacterial, oomycete, fungal, plant, and invertebrate symbionts, pathogens and pests.
2 review criteria on file · agency frameworkSee which genomics opportunities fit your work
An account is free and shows the full announcement, the review criteria reviewers score you against, and whether you are actually eligible — including the windows that close before the deadline does.
No card required.